RLX, CAS [[4425-23-4]]

Produktübersicht

• Artikelname: RLX, CAS [[4425-23-4]]
• Artikelnummer: TGM-T24715
• Hersteller Artikelnummer: T24715
• Alternativnummer: TGM-T24715-1MG,TGM-T24715-5MG,TGM-T24715-10MG,TGM-T24715-25MG,TGM-T24715-50MG,TGM-T24715-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: PD-139530 , THA Q , THA-Q , PD 139530 , PD139530

Produktbeschreibung

RLX (PD 139530) is a PI3K/Akt/FoxO3a signal inhibitor with anticancer activity against tumour cell lines such as colon cancer, inducing sub-G1 arrest and mitochondrial potential loss, thereby inhibiting tumour growth. RLX also exhibits antitussive and anti-asthmatic activity, reducing eosinophils and total lymphocytes in bronchoalveolar lavage (BAL) fluid, and exhibits toxicity toward A549 cells.

Produkteigenschaften

• Molekulargewicht: 214.26
• Reinheit: 99.81%
• CAS Nummer: [4425-23-4]
• Formel: C13H14N2O
• Target-Kategorie: Others|||PI3K|||Akt|||FOXO

Bilder

T24715

T24715

T24715